Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease - Evaluation Study for MRI Utilization -.
- Conditions
- Chronic Kidney Disease
- Registration Number
- JPRN-UMIN000051443
- Lead Sponsor
- Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Not provided
(1) Patients deemed inappropriate by the principal investigator (e.g., after introduction of renal replacement therapy, children (under 18 years old), acute kidney injury, unilateral renal disease (e.g., renal vascular hypertension), renal tumor, severe edematous disease (e.g., nephrotic syndrome), cystic disease, postrenal kidney disease) (2) Patients who have changed the content of the given medication in the initial entry (At the time of the change in the content of the medication because the purpose is to confirm the baseline [MRI, biomarkers] of the case.) (3) Those whose MRI images or laboratory test results are deemed inappropriate for evaluation (When the renal parenchyma is poorly delineated on MRI due to artifacts from body movement, atrophy, cysts, scarring, etc., or when the specimen acquisition and processing process is inappropriate and is inferred not to reflect the pathophysiology of the subject)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Results of blood and urine biomarkers and magnetic resonance imaging.
- Secondary Outcome Measures
Name Time Method